How to Safely Taper Off Antidepressants: The Science of Hyperbolic Tapering

Medical disclaimer: This guide is for educational purposes, based on peer-reviewed research and personal experience. It is not medical advice and should not replace consultation with your doctor. Never stop or change psychiatric medication without professional guidance.

Table of Contents

TL;DR

Antidepressant tapering isn’t linear. Dropping from 60mg to 20mg removes only ~7% of the drug’s effect. Dropping from 5mg to 1.5mg removes ~30%.

This is why standard tapers can cause significant difficulty at the end. The “halving” approach (60→30→15→0) produces the largest pharmacological drops when the doses look smallest.

Withdrawal ≠ relapse. Withdrawal hits fast (days), feels physical and strange. Relapse creeps in slowly (weeks) and feels familiar.

Current research suggests: Tapering by percentage of effect, not milligrams, may reduce withdrawal severity. Tracking symptoms and working closely with your prescriber can help distinguish withdrawal from relapse. [3]

Why I’m Writing This

I’ve been on and off antidepressants for years. The list includes: fluoxetine, sertraline, paroxetine, duloxetine, venlafaxine, citalopram, escitalopram, vortioxetine, and mirtazapine, plus benzodiazepines and antipsychotics.

Not once was I told that antidepressants cause neuroadaptation: the brain physically adapts to the presence of the drug, adjusting its own chemistry to compensate. When you remove the medication, the brain doesn’t instantly snap back. It needs time to re-adapt, and that process can be deeply unpleasant.

Every time I stopped or switched medications, I was blindsided by symptoms I didn’t understand.

This post is what I wish someone had explained to me before my first prescription.

The Myth of the Linear Taper

Like most people, I assumed tapering was straightforward. If you’re on 60mg, you go to 30, then 15, then zero. Makes sense, right?

It doesn’t work that way.

To understand why, you need a quick bit of neurobiology. Don’t worry: I’ll keep it simple.

How SSRIs Actually Work

Your brain has cells called neurons. They communicate by sending chemical messengers (like serotonin) across tiny gaps called synapses. The sender releases serotonin, it drifts across, and the receiver picks up the signal.

Here’s the key mechanism: reuptake. After serotonin delivers its message, the sender recycles it, hoovers it back up for reuse.

SSRIs (Selective Serotonin Reuptake Inhibitors) block this recycling. More serotonin stays in the gap, more signals get through. That’s the therapeutic effect. [1]

A note on the “serotonin hypothesis”: the idea that depression is caused by “low serotonin” is contested in current research. SSRIs clearly do something that helps many people, but the mechanism is likely more complex than simple chemical imbalance. I’m explaining the receptor model because it’s what makes the tapering science make sense, not because it’s the complete picture of depression. [2]

The Hyperbolic Receptor Occupancy Curve

Here’s what nobody tells you: the relationship between dose and effect isn’t linear. It’s hyperbolic.

You’d expect 20mg to block twice as many transporters as 10mg. But that’s not what happens.

Look at these numbers for citalopram: [3]

Dose	Transporter Blockade
60mg	87.8%
40mg	85.9%
20mg	80.5%
9.1mg	70%
5.4mg	60%
1.5mg	30%
0mg	0%

Read that again.

Dropping from 60mg to 20mg, a 40mg reduction, only removes 7.3% of the blocking effect.

But dropping from 5.4mg to 1.5mg, just a 3.9mg reduction, removes 30%.

This is why standard tapers can cause significant difficulty at the end. The biggest pharmacological drops happen when the doses look smallest.

Why This Matters: The Relapse Trap

Here’s what typically happens:

You taper using the standard “halving” method
The first few drops feel manageable
You hit the lower doses and suddenly feel terrible
Your doctor says: “Your depression is coming back”
You go back on the medication, convinced you need it for life

I’ve done this. Multiple times. Each time I thought it was relapse. It wasn’t.

The Prescribing Cascade

This misdiagnosis can spiral into something called a prescribing cascade:

You taper too fast and develop withdrawal symptoms
These symptoms are interpreted as relapse or “worsening mental health”
Your dose is increased or another medication is added
This deepens physiological dependence
Future tapering attempts become even harder

A note on context: Antidepressant withdrawal is an area of emerging research. The landmark Horowitz & Taylor (2019) paper in The Lancet Psychiatry brought hyperbolic tapering into mainstream discussion relatively recently. [3] Training on this topic varies, and many clinicians are now updating their practice as the evidence base develops. NICE guidelines were updated in 2022 to reflect new understanding of withdrawal severity and duration. [4]

This is why being informed matters: not to override your doctor’s judgment, but to have a productive conversation about your individual circumstances.

Withdrawal vs. Relapse: How to Tell the Difference

This distinction is critical. Get it wrong and you may stay on medication longer than necessary. [4]

Feature	Withdrawal	Relapse
Onset	Fast: within days of dose change	Slow: develops over weeks/months
Physical symptoms	Prominent: brain zaps, dizziness, nausea, flu-like aches	Rare: mainly mood and energy changes
How it feels	Strange and unfamiliar: sensations you’ve never had	Familiar: feels like your “old self”
Response to dose	Immediate relief if dose is reinstated	Takes weeks for medication to help

What Withdrawal Actually Looks Like

These vary by person and medication. I’m grouping them by category so you know what to watch for. [5]

Most Common

“Brain zaps”: electric shock sensations in your head, especially when moving your eyes
Dizziness and vertigo: the room spinning or feeling unsteady
Flu-like symptoms: fatigue, headaches, muscle aches, chills
Nausea and digestive upset
Insomnia and vivid dreams

Less Common But Normal

Tingling or burning sensations (paresthesia)
Visual disturbances: trails behind moving objects
Tinnitus (ringing in ears)
Tremors and restlessness
Nightmares

Akathisia: A Symptom That Deserves Its Own Warning

One withdrawal symptom needs special attention: akathisia.

Akathisia is an intense inner restlessness, not anxiety exactly, but a physical sensation of being unable to stay still. People describe it as “crawling out of my skin” or “a motor running inside me that won’t stop.”

It’s distinct from normal agitation because it feels chemical rather than emotional. You’re not worried about anything specific: you just cannot be at rest.

Why this matters: Akathisia is strongly associated with suicidal ideation. [8] The sensation can be so unbearable that people become desperate for relief.

If you experience akathisia during tapering, contact your prescriber or seek medical attention immediately. This symptom requires professional assessment and management. Do not attempt to manage it alone.

Psychological Symptoms

This is where it gets tricky: these overlap with depression/anxiety but present differently.

Anxiety without a target: not “I’m scared of X” but a wordless gut feeling that you’d be safer at home
Irritability and emotional lability: rage or crying that feels out of character
Depersonalisation: feeling detached from your body or reality
Brain fog: difficulty concentrating

The psychological symptoms are harder to spot because there’s no obvious causal link. “I tapered and now I have headaches”: clear. “I tapered and now I feel a vague dread about leaving the house”: less clear. But both can be withdrawal.

“Neuro-Emotions”: It’s the Chemistry, Not Your Character

Here’s a concept that helped me enormously: neuro-emotions.

During withdrawal, your limbic system (the brain’s emotional centre) is firing chaotically due to neurochemical instability. The result is emotional states that are generated by the chemistry itself, not by your circumstances, your psychology, or anything “real.”

This can include:

Spontaneous rage: sudden, explosive anger over nothing
Uncontrollable crying: not sad, just… leaking
Free-floating dread: terror without a source
Emotional hypersensitivity: everything feels too much

The reframe that helps: “This is a symptom, not me. It’s the chemistry, not my character.”

This isn’t dismissing your experience: it’s contextualising it. Knowing that these states can be withdrawal artefacts, not evidence of underlying pathology, can prevent the spiral of “I’m getting worse, I must need the medication.”

A Note for Neurodivergent Readers

If you’re autistic, ADHD, or have sensory processing differences, withdrawal can hit differently, and harder.

Sensory amplification. Many neurodivergent people already have lower thresholds for sensory input. The physical sensations of withdrawal (zaps, dizziness, skin crawling) aren’t just uncomfortable; they can be overwhelming. What registers as a 4/10 annoyance for a neurotypical person might be a 10/10 sensory assault.

Gating failures. Your brain’s ability to filter out irrelevant sensory noise (sensory gating) can be compromised during withdrawal. Lights too bright, sounds too loud, textures unbearable: withdrawal can trigger a state of sensory overload that compounds the chemical distress.

The meltdown mimic. A withdrawal-induced meltdown (from sensory overload + chemical instability) can look identical to a “psychiatric episode” to an untrained eye. This creates a diagnostic trap: instead of recognising withdrawal, a clinician might diagnose worsening mental health and increase medication.

Practical implication: If you’re neurodivergent, discuss with your prescriber whether slower reductions might be appropriate. Some patients find 5% reductions more tolerable than 10%.

The flip side: Neurodivergent strengths in pattern recognition and systemising can actually be an asset here. The detailed tracking, precise calculations, and methodical approach that hyperbolic tapering requires? That’s where many of us excel.

Why Some Drugs Are Harder to Quit: Half-Life

Different antidepressants leave your body at different rates. This matters enormously for withdrawal severity.

Drug	Half-Life	Withdrawal Character
Fluoxetine (Prozac)	4-6 days	Mild, delayed. Often “self-tapers.”
Sertraline (Zoloft)	~26 hours	Moderate. Manageable with care.
Citalopram (Celexa)	~35 hours	Moderate. Similar to sertraline.
Duloxetine (Cymbalta)	~12 hours	Sharp, fast. Notoriously difficult.
Venlafaxine (Effexor)	~5 hours	Very sharp. Often severe.
Paroxetine (Paxil)	~21 hours	Severe despite moderate half-life.

This is why some prescribers use a “fluoxetine bridge”: switching to fluoxetine before tapering, because its long half-life creates a gentler off-ramp. The brain adjusts gradually instead of experiencing a sharp “cliff edge” drop-off.

What the Research Says About Safe Tapering

According to Horowitz & Taylor (2019) and NICE guidelines (2022), the following principles may help reduce withdrawal severity: [3][4]

1. Taper by Effect, Not Milligrams

Instead of halving doses, reducing by a consistent percentage of receptor occupancy (typically 5-10% at a time) may produce more tolerable reductions. This often means:

Larger mg drops early on
Tiny mg drops at the end
Possibly switching to liquid formulation for precise micro-doses

Practical note: If you think you might need liquid formulation, ask your pharmacist about availability before you reach the micro-dosing stage. Not all medications come in liquid form, and supply can be inconsistent.

2. Keep a Taper Journal

Tracking three things daily can help both you and your prescriber identify patterns:

Dose taken: what you actually took
Primary physical symptom (1-10): e.g., “Dizziness: 6/10”
Mood/anxiety (1-10): e.g., “Anxiety: 3/10”

This data helps distinguish patterns from noise and supports productive conversations with your healthcare team.

3. Know the Warning Signs

Signs that may indicate tapering is progressing too quickly include:

The “cliff effect”: feeling fine for days, then suddenly crashing
Incapacitation: too dizzy to drive, too nauseous to eat
Extreme emotional swings: rage or sobbing that feels totally out of character
Suicidal thoughts: any sudden onset of self-harm ideation is a medical emergency. Contact your doctor, call NHS 111 (option 2), or attend A&E immediately.

4. Standard Tapering Protocols

According to current guidelines: [4]

If symptoms are moderate to severe: Standard protocols often recommend pausing reductions and maintaining the current dose until stability returns (typically 1-2 weeks).
If symptoms are severe or unbearable: Guidelines suggest patients discuss with their prescriber whether reinstating the last tolerable dose might be appropriate.
For sensitive patients: Some patients find liquid formulations helpful for making smaller adjustments (e.g., 1mg reductions).

5. Understand the Timeline

Standard withdrawal: Symptoms typically start 2-4 days after a reduction and last 1-3 weeks.
Protracted withdrawal: In some cases, especially with long-term use or short half-life drugs, symptoms can persist for months. [6]

The brain takes longer to adjust coming off than going on. This is normal. It doesn’t mean something is wrong with you.

How to Talk to Your Doctor

If you’re considering tapering, here’s how to have a productive conversation with your prescriber:

Before Your Appointment

Bring information:

How long you’ve been on the medication
Previous tapering attempts and what happened
Current symptoms you’re concerned about
A copy of the Horowitz & Taylor (2019) paper if you want to discuss hyperbolic tapering (freely available at: https://doi.org/10.1016/S2215-0366(19)30032-X)

Know what to ask:

“Can we discuss a gradual tapering plan?”
“What dose reductions would you recommend, and how often?”
“Is liquid formulation available for this medication?”
“What symptoms should prompt me to contact you?”
“How will we distinguish withdrawal from relapse?”

During the Conversation

Frame it collaboratively:

“I’ve been reading about hyperbolic tapering. Is this something we could consider?”
“I want to make sure we have a plan for if I experience withdrawal symptoms.”
“What’s your experience with patients tapering this medication?”

Be honest about your concerns:

If you’ve had difficult experiences with previous tapers, say so
If you’re worried about being dismissed, you can say: “I know withdrawal is an area where the evidence has been evolving. I’d appreciate if we could discuss this together.”

If You Feel Unheard

Ask for a second opinion or referral to a psychiatrist
Contact the Royal College of Psychiatrists patient information service
NICE guideline NG215 specifically addresses withdrawal: you can reference this

Resources to Print and Bring

NICE guideline NG215: “Medicines associated with dependence or withdrawal symptoms” (2022)
Royal College of Psychiatrists patient leaflet: “Stopping antidepressants”
Horowitz & Taylor (2019), The Lancet Psychiatry

My Current Taper: What It Actually Looks Like

I’m currently tapering duloxetine: one of the harder ones because of its short half-life.

I dropped from 60mg to 30mg. It was unpleasant, but manageable. Knowing what to expect made a huge difference. I wasn’t panicking about mysterious symptoms; I had context.

After three weeks at 30mg, I started a much slower taper: 30mg to 25mg. After 2 weeks I went to 20 then 15 and finally, 10mg – where I am now. Next stop will be 7.5mg.

What I experienced:

“Brain lag”: when I moved my eyes or turned my head sharply, there was a jolt-like sensation. Uncomfortable but not painful. This disappeared around the two-week mark.
Tension headaches
A couple of nightmares

So far, so manageable.

A Lesson From Escitalopram: When Withdrawal Leaves a Mark

My worst withdrawal experience was escitalopram. Less brain zaps: more a pervasive sense of dread and nervousness.

I believe I developed PPPD (Persistent Postural-Perceptual Dizziness) from tapering too quickly. The vestibular system, your balance system, is heavily influenced by serotonin. A rapid taper can dysregulate it, leaving you stuck in a chronic “woozy” state that doesn’t respond to typical anxiety treatments.

PPPD is frustrating because it doesn’t show up on any test. It’s diagnosed by criteria from the Bárány Society based on symptoms: persistent non-spinning dizziness, unsteadiness, or hypersensitivity to motion that lasts months. It doesn’t feel like “normal” anxiety: it’s there whether you’re stressed or relaxed, at home or out, and it doesn’t respond to things like alcohol or benzodiazepines the way anxiety typically would.

Treatment involves a combination of SSRIs (ironically), vestibular physiotherapy, and CBT for the associated anxiety. I’ll write a dedicated post on PPPD and other “psychosomatic-looking” symptoms that can follow antidepressant withdrawal: because getting this diagnosis saved my sanity after months of thinking I was going mad.

A Warning About Kindling

Here’s something I wish I’d known earlier: going up and down on medications, swapping and changing chaotically, may contribute to a phenomenon known as kindling. [7]

Kindling is a hypothesis, not yet settled science, that suggests the brain can become hypersensitive to neurochemical changes through repeated cycles of withdrawal and reinstatement. The term comes from epilepsy research, where repeated small seizures eventually lower the threshold for spontaneous seizures.

In psychiatry, the kindling model has been proposed to explain why bipolar disorder sometimes worsens with age, mood swings becoming more frequent and severe over time. There’s also research suggesting similar sensitisation effects with alcohol and benzodiazepine withdrawal.

I don’t know for certain whether this applies to my situation. I have been chaotic with medications: reinstating when I was actually withdrawing, switching drugs repeatedly. I’m now much more careful about stability, and I think the principle of “don’t yo-yo if you can avoid it” is sound, even if the underlying mechanism isn’t fully understood.

If you’ve been chaotic with medications in the past, this doesn’t mean you’ve caused permanent damage. The brain remains plastic throughout life: that’s the whole reason neuroadaptation happens in the first place.

A Harder Question: Tardive Dysphoria

I want to mention something that’s controversial but worth knowing about: the concept of tardive dysphoria.

Some researchers, notably El-Mallakh and colleagues, have proposed that long-term antidepressant use might, in some cases, actually induce a chronic, treatment-resistant depressive state. [9]

The proposed mechanism: your brain’s compensatory response (oppositional tolerance) becomes so entrenched over years that it creates a chronic deficit. Stay on the drug, and the dysphoria continues because the drug is driving the opposition. Stop the drug, and the opposition is unopposed: you crash.

I want to be clear: this is a hypothesis, not established fact. The evidence is mixed, and it doesn’t mean antidepressants are harmful for everyone or that you should stop taking them. For many people, they’re genuinely helpful and life-saving.

But if you’ve been on antidepressants for many years, feel persistently flat or “treatment-resistant,” and are considering tapering: this is context worth discussing with your prescriber. Slow tapering may be the only path forward, and it requires patience measured in months or years, not weeks.

Conclusion: You’re Not Broken

The standard narrative around antidepressants focuses almost entirely on starting them. “You might feel worse before you feel better.” Fine. But nobody tells you that coming off follows the same pattern, or that the brain’s adjustment period is often longer on the way out.

Nobody tells you that the receptor occupancy curve is hyperbolic, that the final milligrams are where the real pharmacological action happens.

Nobody tells you how to distinguish withdrawal from relapse, so you might end up staying on medication longer than you need to, convinced your condition is worse than it is.

This isn’t your fault. The information exists: it’s just not always reaching patients.

If you’re planning to taper:

Work with your prescriber. Share your concerns and this information.
Go slow. Slower than you think.
Track your symptoms. Data helps everyone.
Know that withdrawal symptoms are real, physical, and temporary.
Don’t let anyone, including yourself, mistake withdrawal for failure.

Your brain adapted to the medication. It will adapt back. It just needs time.

What’s Next

This is part of my ongoing series on antidepressants: the stuff I wish I’d been told. Coming up:

PPPD and “psychosomatic” symptoms: what happens when withdrawal leaves lasting traces
The kindling hypothesis: a deeper dive into sensitisation
Alternatives to try before medication: what the research actually says

If this helped, share it with someone who needs it. And subscribe to Matter and Muscle for the rest of the series.

Important Disclaimer

This post is educational, not medical advice. I’m a medical student sharing research and personal experience, not a prescribing clinician. I am not yet qualified to give medical advice, and nothing in this post should be taken as such. Never stop or change psychiatric medication without consulting your doctor. If you’re experiencing severe withdrawal or mental health crisis, seek professional help immediately.

Crisis Resources:

UK: Samaritans: 116 123 (free, 24/7)
UK: NHS Mental Health Crisis Line: 111, option 2
UK: SHOUT text line: text “SHOUT” to 85258
US: National Suicide Prevention Lifeline: 988
International: findahelpline.com

Glossary

Akathisia: Intense inner restlessness; feeling unable to stay still. Strongly associated with suicidality during withdrawal. Requires immediate medical attention.

Brain zaps: Brief electric shock-like sensations in the head, commonly triggered by eye movement. A hallmark of SSRI/SNRI withdrawal.

Depersonalisation: Feeling detached from your own body, thoughts, or identity: like watching yourself from outside.

Discontinuation syndrome: The medical term for antidepressant withdrawal symptoms. Some argue the term downplays severity.

Half-life: The time it takes for half the drug to leave your bloodstream. Short half-life = faster drop = sharper withdrawal.

Hyperbolic tapering: A tapering method that accounts for the non-linear relationship between dose and receptor occupancy, using progressively smaller dose reductions.

Kindling: A hypothesis that repeated cycles of withdrawal and reinstatement may sensitise the brain, making subsequent withdrawals more difficult.

Neuroadaptation: The brain’s process of adjusting its own chemistry in response to a drug. Explains why stopping suddenly causes problems: the brain has adapted to expect the drug.

Neuro-emotions: Emotional states generated by neurochemical instability rather than external circumstances or psychology.

Paresthesia: Tingling, burning, or “pins and needles” sensations on the skin.

PPPD (Persistent Postural-Perceptual Dizziness): A chronic dizziness condition that can develop after vestibular insults, including rapid antidepressant withdrawal.

Prescribing cascade: When drug side effects or withdrawal symptoms are misdiagnosed, leading to additional prescriptions that may deepen dependence.

Receptor occupancy: The percentage of target receptors (e.g., serotonin transporters) that are bound by a drug at a given dose.

Reuptake: The process by which neurotransmitters are recycled back into the sending neuron. SSRIs block serotonin reuptake.

SNRI: Serotonin-Norepinephrine Reuptake Inhibitor. Blocks reuptake of both serotonin and norepinephrine. Examples: duloxetine, venlafaxine.

SSRI: Selective Serotonin Reuptake Inhibitor. Blocks reuptake of serotonin specifically. Examples: fluoxetine, sertraline, citalopram.

Synapse: The tiny gap between neurons where chemical messengers (neurotransmitters) pass signals.

Tardive dysphoria: A proposed chronic depressive state induced by long-term antidepressant use through oppositional tolerance. Hypothesis, not established fact.

Vestibular system: The sensory system responsible for balance and spatial orientation, located in the inner ear. Heavily influenced by serotonin.

References

[1] Stahl, S.M. (2021). Stahl’s Essential Psychopharmacology, 5th ed. Cambridge University Press. Chapter on antidepressants and mechanism of action.

[2] Moncrieff, J., et al. (2022). “The serotonin theory of depression: a systematic umbrella review of the evidence.” Molecular Psychiatry. https://doi.org/10.1038/s41380-022-01661-0

[3] Horowitz, M.A. & Taylor, D. (2019). “Tapering of SSRI treatment to mitigate withdrawal symptoms.” The Lancet Psychiatry, 6(6), 538-546. https://doi.org/10.1016/S2215-0366(19)30032-X

[4] NICE (2022). “Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults.” NICE guideline [NG215]. https://www.nice.org.uk/guidance/ng215

[5] Fava, G.A., et al. (2015). “Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review.” Psychotherapy and Psychosomatics, 84(2), 72-81. https://doi.org/10.1159/000370338

[6] Davies, J. & Read, J. (2019). “A systematic review into the incidence, severity and duration of antidepressant withdrawal effects.” Addictive Behaviors, 97, 111-121. https://doi.org/10.1016/j.addbeh.2018.08.027

[7] Post, R.M. (2007). “Kindling and sensitization as models for affective episode recurrence, cyclicity, and tolerance phenomena.” Neuroscience & Biobehavioral Reviews, 31(6), 858-873. https://doi.org/10.1016/j.neubiorev.2007.04.003

[8] Healy, D., Herxheimer, A., & Menkes, D.B. (2006). “Antidepressants and violence: problems at the interface of medicine and law.” PLoS Med, 3(9), e372. https://doi.org/10.1371/journal.pmed.0030372

[9] El-Mallakh, R.S., Gao, Y., & Roberts, R.J. (2011). “Tardive dysphoria: the role of long term antidepressant use in inducing chronic depression.” Medical Hypotheses, 76(6), 769-773. https://doi.org/10.1016/j.mehy.2011.01.020

Additional Resources:

Royal College of Psychiatrists: “Stopping antidepressants”: rcpsych.ac.uk
NICE guideline NG215: nice.org.uk/guidance/ng215
Surviving Antidepressants (peer support forum): survivingantidepressants.org
The Inner Compass Initiative: withdrawal.theinnercompass.org